engleski

Discriminative power of CSF tau proteins in primary and secondary tauopathies

The lecture focused on the measurement of potentially useful CSF biomarkers for diagnostic purposes, especially for early differentiation of Alzheimer's disease (as a secondary tauopathy) from other primary tauopathies. The recent results from our laboratory were presented and discussed.

Primary tauopathies; Secondary tauopathies; Alzheimer's disease; CSF; tau proteins; amyloid beta; biomarkers; ELISA

nije evidentirano